ANL Adlai Nortye Ltd Company Short-Term Debt

Adlai Nortye (ANL) - corporate logo

Adlai Nortye Ltd. (ANL) develops high-margin oncology drugs with global sales potential. Stable venture funding enables the company to retain leading R&D specialists and attract compliance experts. Despite the Chinese jurisdiction, management ensures the transparency of global trials. Short-term debt financing demonstrates a liquidity level where the 0.01 indicator expresses the state of the company's current liabilities metric.

Adlai Nortye Limited (ANL) - Company Short-Term Loans and Borrowings from 02/21/2024 to 11/01/2026

Summary analytical data breakdowns for Adlai Nortye Ltd (ANL)

- stock price and consensus target price:
Stock Price Adlai Nortye Limited|ANL - Average Forecast Price
- market capitalization data:
Market Value Adlai Nortye Ltd.|ANL - Value Adjusted for Debt and Cash
- shareholders' equity book value data:
Accounting Value per Share Adlai Nortye|ANL - Accounting Value of Company|Market Capitalization to Book Value Ratio adlainortye.com|ANL - Cumulative Company Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Adlai Nortye Ltd.|ANL - Long-Term Debt to Capital|Short-Term Debt to Equity Adlai Nortye Limited|ANL - Aggregate Debt Obligations|Debts to Book Capitalization Adlai Nortye Ltd.|ANL - Long-Term Debt|Company Short-Term Debts Adlai Nortye|Quick Ratio adlainortye.com
- earnings and valuation multiples indicators:
ANL - Company Profit
General company analysis:adlainortye.com (ANL)
Flagship merchandise of Adlai Nortye Limited

For a fundamental valuation of Adlai Nortye Ltd. (ANL), understanding the liability structure that ensures current business viability is critical. By analyzing the short-term debt trend, an investor can determine the volume of borrowings used for operational activities, which, given the dependence of Adlai Nortye Ltd. (ANL) on its R&D pipeline and high capital burn rate, allows for the management of liquidity risks until revenue reaches a stable level.

Main competitors

BeiGene - Company Short-Term Debts|Short-Term Debt Halozyme Therapeutics, Inc.|RevMed (RVMD) - Company Short-Term Debt|Ascentage Pharma Corp - Company Short-Term Loans and Borrowings|Company Current Liabilities CGON|URGN: Company Short-Term Loans and Borrowings|Company Short-Term Debts BCAX|Company Current Liabilities Personalis Inc PSNL|Erasca Corp - Company Current Liabilities|Company Short-Term Debts Delcath Corp DCTH|YMAB - Company Short-Term Debt|Company Short-Term Loans and Borrowings AURA (aurabiosciences.com)|CADL: Company Short-Term Debts|Short-Term Debt Accuray Inc (ARAY)|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Company Short-Term Debts Actuate Therapeutics Inc|Company Short-Term Debts CTOR|tuhurabio.com - Company Short-Term Indebtedness|Company Short-Term Debt Protara Therapeutics, Inc. TARA|Fate Therapeutics Inc - Company Short-Term Debt|Aadi Bio - Company Short-Term Debts|TCRX - Company Short-Term Debts|CSBR: Company Short-Term Debts|XBIT - Short-Term Debt Volume|Company Current Liabilities CVM|OSTX: Company Short-Term Loans and Borrowings|Company Short-Term Debt Radiopharm Theranostics (RADX)|artivabio.com - Company Short-Term Indebtedness|Company Short-Term Debt Veru Inc. VERU|tempesttx.com (TPST) - Short-Term Debt|XLO - Company Short-Term Debt|Company Short-Term Loans and Borrowings RENB (Renovaro Inc.)|MURA (muraloncology.com) - Company Current Liabilities|KAPA: Amount of Current Liabilities|Company Current Liabilities OKUR|Short-Term Debt CytoMed GDTC|Company Short-Term Debts CRIS|APLM - Short-Term Debt|Tharimmune Corp - Company Current Liabilities|Company Short-Term Loans and Borrowings ADVB|GNPX - Company Short-Term Debt|CLDI: Company Short-Term Debt|SBFM (Sunshine Biopharma) - Company Current Liabilities|XBIO: Amount of Current Liabilities|SLRX (Salarius) - Company Short-Term Debts|Company Short-Term Indebtedness PPBT (Kitov Pharma)|Company Current Liabilities AONC (American Oncology Network)|Short-Term Debt Volume beigene.com|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|Company Short-Term Debts Elevation Oncology Inc. ELEV|ICAD - Company Short-Term Debt|IKNA (Ikena Oncology, Inc.) - Company Short-Term Indebtedness|Notable Labs, Ltd. (NTBL) - Company Short-Term Debt|VIRX (Viracta Therapeutics, Inc.) - Company Short-Term Debt|MOR (MorphoSys) - Company Short-Term Debts|Company Current Liabilities NAYA Biosciences Inc (NAYA)|Company Short-Term Debts AAPGV